Professor Kiarash Khosrotehrani
Professor

Kiarash Khosrotehrani

Email: 
Phone: 
+61 7 344 37088

Background

Professor Khosrotehrani is a clinical scientist, dircetor of the Frazer institute, the university of Queensalnd, sharing his passion for academic medicine and translation of science discorveries into real world solutions for patients. Prof Khosrotehrani is a dermatologist, interested in skin biology, regenerative medicine and skin cancer. He leads the Experimental Dermatology Group at the University of Queensland Frazer Institute within the Translational Research Institute in Brisbane, Australia. Dr Khosrotehrani obtained his MD from the Cochin-Port Royal School of Medicine at René Descartes University, Paris, France, where he specialized in Dermatology. He is a former graduate of the Ecole Normale Supérieure and the Institut Pasteur of Paris (Université Paris VI, Pierre et Marie Curie) where he obtained a PhD in Physiology and Physiopathology. He is a fellow of the Australian College of Dermatologists and a practising dermatologist at the Princess Alexandra Hospital, Prince Charles Hospital and the Skin and Cancer Foundation’s Queensland Institute of Dermatology.

As the inaugural St Baker-Soyer chair of Dermatology at the University of Queensland, Professor Khosrotehrani is a national leader in the discipline of Dermatology. He is a board director at the Australasian College of Dermatologists and the Queensland Skin and Cancer Foundation and the director of the Dermatology Department at the Princess Alexandra Hospital. He has held multiple leadership roles as past-President of the Australasian Society for Dermatology Research, Editor in chief of the Australasian Journal of Dermatology and board member of the International Society of investigative Dermatology.

During his post-doctoral training at Tufts-New England Medical Center, Boston, USA, Dr. Khosrotehrani helped establish the contribution of fetal stem cells to tissue repair by demonstrating their multipotent capacity with a specific potency towards the endothelial lineage. The originality of this work was acknowledged by the NHMRC through an achievement award (2011) and an NHMRC excellence award (2016). The main focus of his laboratory is on regenerative medicine and stem cell biology in particular in injury response in skin wounds and skin cancer and how these responses contribute to cancer initiation and progression. Translating his laboratory findings, Dr Khosrotehrani is leading innovative clinical trials in wound healing, keratinocyte cancers and melanoma.

Availability

Professor Kiarash Khosrotehrani is:
Available for supervision
Media expert

Fields of research

Biomedical and Clinical Sciences Cancer genetics Clinical sciences Dermatology Medical biotechnology Oncology and carcinogenesis

Qualifications

  • Doctor of Philosophy, University of Paris

Research interests

  • Tissue regeneration

    Endogenous response to injury. Vascular and Epithelial repair in response to ischemia or wounding. Hair follicle biology, cycling and regeneration.

  • Skin cancer

    Factors determining melanoma survival. Basal Cell carcinoma formation and progression Squamous cell carcinoma formation and UV irradiation

Search Professor Kiarash Khosrotehrani’s works on UQ eSpace

380 works between 2001 and 2025
All (380) Journal Article (239) Other Outputs (1) Conference Publication (132) Book Chapter (8)

21 - 40 of 380 works

2025

Journal Article

Sociodemographic disparities in melanoma stage at diagnosis: the role of socioeconomic status and residential location

Gavanescu, Danielle, Dobson, Annette, Sharma, Hansa, Tan, Samuel X., Muller, Nicholas M., Hughes, Maria Celia B., Malt, Maryrose K., Smithers, B. Mark, Khosrotehrani, Kiarash and von Schuckmann, Lena A. (2025). Sociodemographic disparities in melanoma stage at diagnosis: the role of socioeconomic status and residential location. Cancer Epidemiology, Biomarkers and Prevention, 34 (10), 1771-1775. doi: 10.1158/1055-9965.epi-25-0372

Sociodemographic disparities in melanoma stage at diagnosis: the role of socioeconomic status and residential location

2025

Journal Article

Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise

Thomas, Meryl, Hankins, Madeline, Darchini‐Maragheh, Emadodin, Bokhari, Laita, Eisman, Samantha, Yip, Leona, York, Katherine, Li, Jane, Sharma, Pooja, Triwongwaranat, Daranporn, Chitreddy, Vijaya, Ghiya, Ragini, Kushnir‐Grinbaum, Daniella, Frewen, John, Yong, Shin Shen, Rathnayake, Deepani, Cranwell, William, Wall, Dmitri, Varathan, Vanathy, Khosrotehrani, Kiarash, Orchard, David, Moussa, Anthony, Paranjape, Meghana and Sinclair, Rodney (2025). Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise. Australasian Journal of Dermatology, 66 (7) ajd.14556, 404-412. doi: 10.1111/ajd.14556

Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise

2025

Conference Publication

Topical sirolimus prevents cutaneous squamous cell carcinomas by disrupting the balance between differentiation and proliferation

Dousset, L., Zhou, C., Kao, Y., Tan, S., Muller, N., Sormani, L., Cox, C., Soyer, H.P., Stark, M.S., Wong, H., Roy, E. and Khosrotehrani, K. (2025). Topical sirolimus prevents cutaneous squamous cell carcinomas by disrupting the balance between differentiation and proliferation. Society for Investigative Dermatology (SID) 2025 Meeting, San Diego, CA United States, 7-10 May 2025. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2025.06.777

Topical sirolimus prevents cutaneous squamous cell carcinomas by disrupting the balance between differentiation and proliferation

2025

Conference Publication

Spatial transcriptomics reveals molecular determinants of mortality in thin melanoma

Zhou, C., Tan, S.X., Kao, Y., Claeson, M., Brown, S., Lambie, D., Whiteman, D.C., Pandeya, N., Olsen, C.M., Barbour, A., MacGregor, S., Soyer, H.P., Stark, M.S., Hayward, N., Smithers, B.M., Nguyen, Q. and Khosrotehrani, K. (2025). Spatial transcriptomics reveals molecular determinants of mortality in thin melanoma. Society for Investigative Dermatology (SID) 2025 Meeting, San Diego, CA United States, 7-10 May 2025. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2025.06.109

Spatial transcriptomics reveals molecular determinants of mortality in thin melanoma

2025

Conference Publication

Epithelial-mesenchymal transition and immune exclusion underpin the natural history of primary cutaneous melanoma

Tan, S.X., Muller, N., Zhou, C., Vipulaguna, N., Kao, Y., Whiteman, D.C., Soyer, H.P., Stark, M.S., Nguyen, Q. and Khosrotehrani, K. (2025). Epithelial-mesenchymal transition and immune exclusion underpin the natural history of primary cutaneous melanoma. Society for Investigative Dermatology (SID) 2025 Meeting, San Diego, CA United States, 7-10 May 2025. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2025.06.953

Epithelial-mesenchymal transition and immune exclusion underpin the natural history of primary cutaneous melanoma

2025

Other Outputs

Integrating 12 Spatial and Single Cell Technologies to Characterise Tumour Neighbourhoods and Cellular Interactions in three Skin Cancer Types

Prakrithi, P., Grice, Laura F., Zhang, Feng, Hockey, Levi, Tan, Samuel X., Tan, Xiao, Xiong, Zherui, Mulay, Onkar, Causer, Andrew, Newman, Andrew, Pham, Duy, Ni, Guiyan, Tuong, Kelvin, Jin, Xinnan, Kim, Eunju, Tran, Minh, Vu, Hani, Muller, Nicholas M., Killingbeck, Emily E., Gregory, Mark T., Teoh, Siok Min, Vo, Tuan, Zhang, Min, Landi, Maria Teresa, Brown, Kevin M., Iles, Mark M., Reitz, Zachary, Devitt, Katharina, Pan, Liuliu ... Nguyen, Quan (2025). Integrating 12 Spatial and Single Cell Technologies to Characterise Tumour Neighbourhoods and Cellular Interactions in three Skin Cancer Types. doi: 10.1101/2025.07.25.666708

Integrating 12 Spatial and Single Cell Technologies to Characterise Tumour Neighbourhoods and Cellular Interactions in three Skin Cancer Types

2025

Journal Article

Bigger might actually be better: A prospective investigation into the association between body mass index, tumour stage, and recurrence in patients with high-risk primary melanoma

Sharma, Hansa, Hughes, Maria Celia B., Gavanescu, Danielle, Malt, Maryrose, Smithers, B Mark, Khosrotehrani, Kiarash and von Schuckmann, Lena (2025). Bigger might actually be better: A prospective investigation into the association between body mass index, tumour stage, and recurrence in patients with high-risk primary melanoma. Journal of the American Academy of Dermatology, 93 (6), 1543-1545. doi: 10.1016/j.jaad.2025.07.043

Bigger might actually be better: A prospective investigation into the association between body mass index, tumour stage, and recurrence in patients with high-risk primary melanoma

2025

Journal Article

The Involvement of IL-34 in Inflammatory and Malignant Skin Diseases

Dang, Thi Viet Trinh, Mehdi, Ahmed M., Kumari, Snehlata, Khosrotehrani, Kiarash, Frazer, Ian H., Hume, David A. and Chandra, Janin (2025). The Involvement of IL-34 in Inflammatory and Malignant Skin Diseases. Journal of Investigative Dermatology, 145 (11), 1-13. doi: 10.1016/j.jid.2025.05.003

The Involvement of IL-34 in Inflammatory and Malignant Skin Diseases

2025

Conference Publication

The effects of body mass index and type 2 diabetes mellitus on melanoma prognosis in patients with high-risk primaries

Sharma, Hansa, Hughes, Maria Celia, Gavanescu, Danielle, Smithers, Mark, Khosrotehrani, Kiarash and Von Schuckmann, Lena (2025). The effects of body mass index and type 2 diabetes mellitus on melanoma prognosis in patients with high-risk primaries. Australasian College of Dermatologists, 57th Annual Scientific Meeting, Brisbane, QLD, Australia, 31 May 2025 – 2 June 2025. Richmond, VIC 3121 Australia: John Wiley & Sons.

The effects of body mass index and type 2 diabetes mellitus on melanoma prognosis in patients with high-risk primaries

2025

Conference Publication

Can diet affect melanoma prognosis? An analysis of the healthy eating index and the mediterranean diet in patients with high-risk primary melanoma

Sharma, Hansa, Hughes, Maria Celia, Gavanescu, Danielle, Smithers, Mark, Khosrotehrani, Kiarash and Von Schuckmann, Lena (2025). Can diet affect melanoma prognosis? An analysis of the healthy eating index and the mediterranean diet in patients with high-risk primary melanoma. Australasian College of Dermatologists, 57th Annual Scientific Meeting, Brisbane, QLD, Australia, 31 May 2025 – 2 June 2025. Richmond, VIC, Australia: John Wiley & Sons.

Can diet affect melanoma prognosis? An analysis of the healthy eating index and the mediterranean diet in patients with high-risk primary melanoma

2025

Conference Publication

Outcomes of checkpoint inhibitors in kidney transplant recipients

Nam, Hyun Jae, Shao, Emily, Cao, Michael, Wong, Kennedy, Khosrotehrani, Kiarash, Isbel, Nicole, Campbell, Scott and Ladwa, Rahul (2025). Outcomes of checkpoint inhibitors in kidney transplant recipients. Australasian College of Dermatologists, 57th Annual Scientific Meeting, Brisbane, QLD, Australia, 31 May 2025 – 2 June 2025. Richmond, VIC, Australia: John Wiley & Sons.

Outcomes of checkpoint inhibitors in kidney transplant recipients

2025

Conference Publication

The first 1000 participants in the Australasian Dermatology Registry

Baker, Christopher, Lehmann, Chelsea, Armstrong, Julie, Anderson, Sue, Chan, Jonathan, Penas, Pablo Fernandez, Kern, Johannes S., Khosrotehrani, Kiarash, Sidhu, Shireen, Youssef, Peter and Foley, Peter (2025). The first 1000 participants in the Australasian Dermatology Registry. Australasian College of Dermatologists, 57th Annual Scientific Meeting, Brisbane, QLD, Australia, 31 May 2025 – 2 June 2025. Richmond, VIC, Australia: John Wiley & Sons.

The first 1000 participants in the Australasian Dermatology Registry

2025

Conference Publication

Can you see me? Development and validation of digital algorithms to identify hidradenitis suppurativa in Queensland

Liu, Timothy, Pham, Hai, Flores, Deborah Toledo, Khosrotehrani, Kiarash, Pole, Jason and McMeniman, Erin (2025). Can you see me? Development and validation of digital algorithms to identify hidradenitis suppurativa in Queensland. Australasian College of Dermatologists, 57th Annual Scientific Meeting, Brisbane, QLD, Australia, 31 May 2025 – 2 June 2025. Richmond, VIC, Australia: John Wiley & Sons.

Can you see me? Development and validation of digital algorithms to identify hidradenitis suppurativa in Queensland

2025

Conference Publication

Ensemble machine learning informs risk of recurrence in primary cutaneous melanoma: a 7-year prospective cohort study

Tan, Samuel, Muller, Nicholas, Gavanescu, Danielle, Sharma, Hansa, Vipulaguna, Nisal, Smithers, Mark, Khosrotehrani, Kiarash and Von Schuckmann, Lena (2025). Ensemble machine learning informs risk of recurrence in primary cutaneous melanoma: a 7-year prospective cohort study. Australasian College of Dermatologists, 57th Annual Scientific Meeting, Brisbane, QLD, Australia, 31 May 2025 – 2 June 2025. Richmond, VIC, Australia: John Wiley & Sons.

Ensemble machine learning informs risk of recurrence in primary cutaneous melanoma: a 7-year prospective cohort study

2025

Conference Publication

Association between occupational UV exposure and melanoma recurrence

Gavanescu, Danielle, Sharma, Hansa, Tan, Samuel, Muller, Nicholas, Von Schuckmann, Lena and Khosrotehrani, Kiarash (2025). Association between occupational UV exposure and melanoma recurrence. Australasian College of Dermatologists, 57th Annual Scientific Meeting, Brisbane, QLD, Australia, 31 May 2025 – 2 June 2025. Richmond, VIC, Australia: John Wiley & Sons.

Association between occupational UV exposure and melanoma recurrence

2025

Conference Publication

Thick versus thin: the natural history of primary melanoma is characterized by Mesenchymal transition and immune exclusion

Tan, Samuel, Muller, Nicholas, Zhou, Chenhao, Kao, Yung-Ching, Vipulaguna, Nisal, Gavanescu, Danielle, Roy, Edwige, Whiteman, David, Soyer, H. Peter, Stark, Mitchell, Nguyen, Quan and Khosrotehrani, Kiarash (2025). Thick versus thin: the natural history of primary melanoma is characterized by Mesenchymal transition and immune exclusion. Australasian College of Dermatologists, 57th Annual Scientific Meeting, Brisbane, QLD, Australia, 31 May 2025 – 2 June 2025. Richmond, VIC, Australia: John Wiley & Sons.

Thick versus thin: the natural history of primary melanoma is characterized by Mesenchymal transition and immune exclusion

2025

Conference Publication

Implementation of a new teledermatology clinic

Stone, Corey, Kelly, Madeleine, Wu, Jason, Khosrotehrani, Kiarash and Soyer, H. Peter (2025). Implementation of a new teledermatology clinic. Australasian College of Dermatologists, 57th Annual Scientific Meeting, Brisbane, QLD, Australia, 31 May-2 June 2025. Richmond, VIC, Australia: John Wiley & Sons.

Implementation of a new teledermatology clinic

2025

Journal Article

Assessment of the Influence of <scp>UVR</scp> in Cutaneous Melanoma

Walker, Graeme J. and Khosrotehrani, Kiarash (2025). Assessment of the Influence of UVR in Cutaneous Melanoma. Photodermatology, Photoimmunology & Photomedicine, 41 (3) e70024, e70024. doi: 10.1111/phpp.70024

Assessment of the Influence of <scp>UVR</scp> in Cutaneous Melanoma

2025

Journal Article

Haematological cancers and skin cancer: statistics from the Netherlands

von Schuckmann, Lena A and Khosrotehrani, Kiarash (2025). Haematological cancers and skin cancer: statistics from the Netherlands. British Journal of Dermatology, 192 (6), 966-967. doi: 10.1093/bjd/ljaf081

Haematological cancers and skin cancer: statistics from the Netherlands

2025

Journal Article

Prognostic markers could extend adjuvant immunotherapy to high-risk Stage IB/IIA melanoma: a modelling study

Tan, Samuel X., Muller, Nicholas, Zhou, Chenhao, Walpole, Euan, Smithers, B. Mark, Whiteman, David C. and Khosrotehrani, Kiarash (2025). Prognostic markers could extend adjuvant immunotherapy to high-risk Stage IB/IIA melanoma: a modelling study. JAAD International, 18, 86-87. doi: 10.1016/j.jdin.2024.09.010

Prognostic markers could extend adjuvant immunotherapy to high-risk Stage IB/IIA melanoma: a modelling study

Current funding

  • 2025 - 2028
    Predicting Early-Stage Melanoma at High Risk of Recurrence through Spatial Transcriptomic Profiling
    United States Congressionally Directed Medical Research Programs - Melanoma Research Program
    Open grant
  • 2025 - 2030
    Skin Cancer in Organ Transplant Recipients
    PA Research Foundation
    Open grant
  • 2025 - 2027
    Targeting Prostaglandin D2 Pathway for Enhanced Therapy in Atopic Dermatitis
    NHMRC Development Grant
    Open grant
  • 2024 - 2026
    Targeting endothelial trans-differentiation in vascular lesions ((NHMRC Ideas Grant) administered by The University of Sydney)
    University of Sydney
    Open grant
  • 2022 - 2027
    The SiroSkin study: A multi-centre randomised double-blind placebo-controlled trial of 1% topical sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ... (Stream 7)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2025
    Post-doctoral fellowship support for oncodermatology
    PA Research Foundation
    Open grant
  • 2024 - 2025
    Onco-Derm: a single site prospective analysis of skin microbiome as a predictor of toxicity in patients receiving immune checkpoint inhibitor therapy
    Microba Pty Ltd
    Open grant
  • 2023 - 2026
    Molecular definition of cellular states in the vascular endothelium
    ARC Discovery Projects
    Open grant
  • 2022 - 2025
    PREDICT: PREcision DIagnostiCs for early melanoma detection using spaTial biology and AI-guided image analysis
    United States Congressionally Directed Medical Research Programs - Melanoma Research Program
    Open grant
  • 2022 - 2024
    Determining Causative Mechanisms of Hidradenitis Suppurativa (TRI LINC grant led by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2022 - 2023
    Manufacturing biological substitutes for wound healing and skin regeneration
    Metro North Hospital and Health Service
    Open grant
  • 2021 - 2024
    Advanced technological approach to predicting survival in patients diagnosed with locally invasive cutaneous melanoma
    Cancer Council Queensland
    Open grant
  • 2021 - 2025
    Long-term protection in the growth restricted newborn
    Cerebral Palsy Alliance
    Open grant
  • 2020 - 2023
    Reducing the burden of skin cancers through advanced chemoimmuno-prophylaxis
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2020 - 2022
    Molecular Targets in Endovascular Progenitors to Inhibit Lung and Skin Fibrosis in Scleroderma
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant
  • 2020 - 2024
    QSKIN: the burden of skin cancer (NHMRC CTCS administered by QIMR Berghofer)
    Queensland Institute of Medical Research
    Open grant
  • 2019 - 2021
    Volumetric Modulated Arc Therapy (VMAT) Irradiation in Skin Cancer Incidence Prevention: A randomised, open-label, single arm, phase II, controlled trial (the Trial)
    Genesis Care Cancer Care Research Pty Ltd
    Open grant
  • 2019 - 2022
    Potency and activity of Meso-Endothelial bipotent progenitors in vivo
    ARC Discovery Projects
    Open grant
  • 2019 - 2022
    Targeting the pre-metastatic vascular niche in melanoma using a novel molecular strategy
    NHMRC Project Grant
    Open grant
  • 2018 - 2019
    Systems Biology of the skin
    Queensland Institute of Medical Research
    Open grant
  • 2018 - 2020
    Improving brain outcomes in the growth restricted newborn using placental stem cell treatment
    Financial Markets Foundation for Children
    Open grant
  • 2018 - 2021
    Fighting epidermal skin cancers by targeting epidermal clones that accumulate mutations
    NHMRC Project Grant
    Open grant
  • 2018 - 2020
    Improved antigen-specific immunotherapy for cutaneous malignant melanoma
    Cancer Council Queensland
    Open grant
  • 2018 - 2021
    Stem cell treatment for neonatal hypoxic ischaemic encephalopathy
    NHMRC Project Grant
    Open grant
  • 2018
    Targeted and personalised early detection of melanoma using a 3D teledermatology network
    PA Research Foundation
    Open grant
  • 2017 - 2018
    Cutting-edge Imaging System for the Early Diagnosis of Face and Scalp Skin Cancer
    The Honda Foundation
    Open grant
  • 2017 - 2020
    Improving brain oxygen levels in babies using stem cell treatment
    The Children's Hospital Foundation
    Open grant
  • 2017 - 2019
    Melanoma environment and heterogeneity in therapy sensitivity and resistance - Khosrotehrani
    Meehan Bequest
    Open grant
  • 2017 - 2020
    Modulating skin regenerative responses to improve wound repair and fight carcinogenesis
    NHMRC Career Development Fellowship
    Open grant
  • 2017 - 2019
    Predictors of mortality in thin melanomas
    Cancer Council Queensland
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Translational dermatology in skin and skin cancer research
    UQ Fellowships
    Open grant
  • 2015 - 2017
    The natural history of skin cancer formation: from normal skin to cancer
    Leo Foundation
    Open grant
  • 2015 - 2018
    Preventing basal cell carcinoma formation by targeting the tumour environment
    Leo Foundation
    Open grant
  • 2015
    Laser doppler perfusion imaging (LDPI) of revascularisation sites following vascular stem cell therapy
    RL Cooper Medical Research Foundation Limited
    Open grant
  • 2015 - 2017
    Role of resident endothelial progenitor cells in melanoma vascularisation and progression
    NHMRC Project Grant
    Open grant
  • 2015 - 2018
    Systems analysis of epidermal biology and cancer (NHMRC Project Grant administered by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2014
    Anti-inflammatory strategies to promote healing of chronic diabetic wounds
    Diabetes Australia Research Trust
    Open grant
  • 2013 - 2014
    Targeting the dermal component of basal cell carcinoma
    Cancer Bequest Fund
    Open grant
  • 2013 - 2014
    A genome wide approach to identify important genetic determinants of skin wound healing
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2013 - 2016
    Innovations in Diabetic Foot Ulcer (DFU) Wound Care (NHMRC Project Grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2013
    Modelling mechanisms of drug responses in infantile haemangiomas (IH) by using placental endothelial progenitor cells (EPC)
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2013 - 2015
    Tracking epidermal clonal evolution during skin cancer induction and progression
    NHMRC Project Grant
    Open grant
  • 2013 - 2014
    Understanding potency and role of individual stem cells in the skin using Rainbow technology
    ARC Discovery Projects
    Open grant
  • 2012 - 2014
    Fetal endothelial progenitors from the placenta as a source for cell therapy
    NHMRC Project Grant
    Open grant
  • 2012
    Multi-user in vivo and ex vivo tissue-level mechanical testing instrument for bone and stem cell research
    NHMRC Equipment Grant
    Open grant
  • 2012 - 2015
    NHMRC Career Development Fellowship (Clinical; Level 1): Stem and progenitor cell contribution to skin wounds and homeostasis
    NHMRC Career Development Award
    Open grant
  • 2012
    Tandem fluorescent and phase-contrast imaging of live cells in real time for application to cancer cell biology, developmental biology, respiratory biology, wound healing investigation and cellular to
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011 - 2013
    Routine assay to determine response to Braf inhibition therapy in melanoma
    UQ Collaboration and Industry Engagement Fund
    Open grant
  • 2011 - 2012
    Role of maternofetal chimerism in transferring susceptibility to MS
    National Multiple Sclerosis Society-US
    Open grant
  • 2011 - 2013
    Development of the routine assay to determine response to Braf inhibition therapy in melanomas
    UQ FirstLink Scheme
    Open grant
  • 2011
    Molecular markers to predict sentinel lymph node invasion and 5-year and 10-year outcomes in patients with stage I and II primary melanoma
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2011
    Persisting host dermal and epidermal antigen presenting cells as predictors of chronic graft versus host disease
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2011
    Predictive value of STAT5 activity in melanoma metastasis and survival
    Royal Brisbane and Women's Hospital
    Open grant
  • 2010
    Macroscopic fluorescence imaging system for identifying and isolating transgenically tagged cells
    NHMRC Equipment Grant
    Open grant
  • 2010
    Multi-user small animal digital x-ray imaging machine for bone, cancer, inflammation and stem cell research
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010 - 2013
    Preclinical optimisation of intrauterine transplantation of fetal mesenchymal stem cells for osteogenesis imperfecta.
    NHMRC Project Grant
    Open grant
  • 2009 - 2010
    Influence of dermal fibroblasts on epidermal stem cell homeostasis in a model of ageing
    Ramaciotti Foundation
    Open grant
  • 2009
    High-end optical in vivo molecular imaging system for stem cells, tumours, tissue repair and pathogens
    UQ School/Centre Co-Funding
    Open grant

Availability

Professor Kiarash Khosrotehrani is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Master Philosophy

    Skin micro-bio-tox: understanding the skin toxicity associated with immune checkpoint inhibitors

    Principal Advisor

    Other advisors: Dr Janin Chandra

  • Master Philosophy

    Spatial omics to characterize the clinicopathologic subsets of melanoma

    Principal Advisor

  • Doctor Philosophy

    Evaluating the impact of social determinants of health on skin cancer outcomes

    Principal Advisor

  • Doctor Philosophy

    Understanding and targeting determinants of mortality from melanoma

    Principal Advisor

    Other advisors: Dr Quan Nguyen, Dr Lena Von Schuckmann

  • Doctor Philosophy

    Spatial imaging to predict survival in melanoma

    Principal Advisor

    Other advisors: Dr Quan Nguyen

  • Doctor Philosophy

    Understanding Melanoma Vascularisation to prevent metastasis

    Associate Advisor

  • Doctor Philosophy

    Understanding immune diversity in skin inflammation

    Associate Advisor

    Other advisors: Professor Gabrielle Belz, Dr Snehlata Kumari

  • Doctor Philosophy

    Predictive and prognostic biomarkers for melanoma progression (BioMEL)

    Associate Advisor

    Other advisors: Associate Professor Mitchell Stark

  • Master Philosophy

    Analysing the association between diet, comorbidities and melanoma prognosis in patients with high-risk primaries

    Associate Advisor

    Other advisors: Dr Lena Von Schuckmann

  • Doctor Philosophy

    Characterizing the role of ion channel kinase in skin homeostasis

    Associate Advisor

    Other advisors: Professor Fiona Simpson, Dr Snehlata Kumari

  • Doctor Philosophy

    Defining the role of non-immune MHCII expression in the development of squamous cell cancers.

    Associate Advisor

    Other advisors: Dr Debottam Sinha, Dr Janin Chandra

  • Doctor Philosophy

    Targeting epigenetic regulation to overcome immunotherapy resistance in cutaneous melanoma

    Associate Advisor

    Other advisors: Professor Nikolas Haass, Dr Abbas Shafiee, Associate Professor Jason Lee

  • Doctor Philosophy

    Novel genomic predictors of survival in thin and thick melanomas

    Associate Advisor

    Other advisors: Associate Professor Mitchell Stark

Completed supervision

Enquiries

Contact Professor Kiarash Khosrotehrani directly for media enquiries about:

  • basal cell carcinoma
  • Dermatology
  • Fetal stem cells
  • Melanoma
  • Skin cancer
  • Skin wound healing
  • squamous cell carcinoma
  • Stem cells - fetal
  • Stem cells - skin wound healing

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au